Company Overview and News
TransEnterix Inc. (TRXC - Free Report) posted a loss of 9 cents per share in third-quarter 2017, in line with the Zacks Consensus Estimate. The company incurred a loss of 11 cents in the year-ago quarter. (70-4)
Good morning ladies and gentlemen, and welcome to the TransEnterix Third Quarter 2017 Financial and Operating Results Conference Call. As a reminder, this conference call is webcast live and recorded. (77-1)
Investors in TransEnterix, Inc. (TRXC - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 17, 2017 $8 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. (62-6)
A study was published in reputable medical journal JAMA stating that laparoscopic surgical bots offer no clinical benefit. (62-6)
TransEnterix, Inc. (TRXC - Free Report) was a big mover last session, as the company saw its shares nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.26–$4.00 in the past one-month time frame, witnessed a sharp increase on Friday. (117-2)
TransEnterix, Inc. (TRXC - Free Report) announced the receipt of FDA 510(k) clearance for the Senhance Surgical Robotic System. Senhance is a multiport surgical robotic system which helps perform minimally invasive surgery.It is the first FDA-approved entrant in the field of abdominal surgical robotics since 2000. This development is going to fortify TransEnterix’s medical device robotics segment’s business. (70-6)
If you want a Stock Review on TRXC, DXTR, MZOR, or XRAY then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Thursday, benchmark US indices were in bullish colors as the NASDAQ Composite closed the trading session flat; the Dow Jones Industrial Average edged 0.18% higher; and the S&P 500 was up 0.12%. US markets made broad based gains with six out of nine sectors finishing the day in green. (174-4)
TransEnterix Inc. (TRXC - Free Report) , a global medical technology company, recently announced that it has filed a response with the FDA related to its Senhance Surgical Robotic System 510(k) submission. The company expects to receive the FDA approval for the system in fiscal 2017 itself. (69-2)
Good afternoon, ladies and gentlemen, and welcome to the TransEnterix Second Quarter 2017 Financial and Operating Results Conference Call. As a reminder, this conference call is webcast live and recorded. It is now my pleasure to introduce your host, Mr. Mark Klausner of Westwood Partners. Please go ahead, sir. (0-5)
If you want a Stock Review on TRXC, DXTR, EKSO or MZOR then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Wednesday, the NASDAQ Composite ended the day at 6,150.86, up 0.67%; the Dow Jones Industrial Average edged 0.01% lower, to finish at 21,478.17; and the S&P 500 closed at 2,432.54, marginally gaining 0.15%. US markets saw a mixed session as 4 sectors closed in green, 4 sectors finished in red, and 1 sector ended flat for the day. (0-1)
Right now, this functional beverage company is rolling. We don’t mean it’s rolling in cash. NBEV has indulged in rolling up other weak companies. We’ve written cautionary notes before about how roll-ups’ flashy announcements get everyone excited, then they briefly get to claim acquisitions’ revenue. Everything looks fine for a while.
Headquartered in Morrisville, NC, TransEnterix, Inc. (TRXC - Free Report) , a global medical technology company, recently announced that it has sold a Senhance Robotic Surgery System to a Japanese customer. The aforementioned system was sold to the Saitama Medical University International Medical Center located in the Saitama Prefecture in the Greater Tokyo region. (0-2)
Good afternoon, ladies and gentlemen and welcome to the TransEnterix First Quarter 2017 Financial and Operating Results Conference Call. As a reminder, this conference call is webcast live and recorded. It is now my pleasure to introduce your host, Mr. Mark Klausner of Westwood Partners. Please go ahead, sir. (0-1)
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
• Shares of Nimble Storage Inc (NMBL - Free Report) soared 46.3% after Hewlett Packard Co (HPE - Free Report) said it would buy the data storage provider for $1.09 billion in cash • Shares of Dicks Sporting Goods Inc (DKS - Free Report) tanked 8.6% after the company declared that it is set to drop 20% of the brands it currently carries • Shares of MeetMe Inc (MEET - Free Report) surged 16.
Stock Research Report
TransEnterix, Inc. is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical challenges associated with current laparoscopic and robotic options. TransEnterix is focused on the commercialization and further development of its Senhance™ Surgical Robotic System (formerly known as the ALF-X ® Surgical Robotic System) (the “Senhance System”), a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology. The Senhance System has been granted a CE Mark in Europe for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, but is not available for sale in the U.S. TransEnterix has also developed the SurgiBot™ System (the “SurgiBot System”), a single-port, robotically enhanced laparoscopic surgical platform. The SurgiBot System is not available for sale in any market.
2017-10-28 - Wilton
2017-10-25 - Wilton
2017-10-10 - Wilton
2017-10-09 - Wilton
2017-08-25 - Wilton